Log in

NYSEAMERICAN:INFUInfuSystem Stock Price, Forecast & News

+0.36 (+3.16 %)
(As of 06/5/2020 04:00 PM ET)
Today's Range
Now: $11.77
50-Day Range N/A
52-Week Range
Now: $11.77
Volume47,694 shs
Average Volume82,739 shs
Market Capitalization$236.22 million
P/E RatioN/A
Dividend YieldN/A
InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Medical Instruments & Supplies



Sales & Book Value

Annual SalesN/A



Market Cap$236.22 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive INFU News and Ratings via Email

Sign-up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.

InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions

When is InfuSystem's next earnings date?

InfuSystem is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for InfuSystem.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) announced its quarterly earnings data on Thursday, March, 19th. The medical instruments supplier reported $0.04 earnings per share for the quarter. The medical instruments supplier earned $21.71 million during the quarter. View InfuSystem's earnings history.

Has InfuSystem been receiving favorable news coverage?

Media coverage about INFU stock has been trending somewhat positive on Saturday, according to InfoTrie. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. InfuSystem earned a news impact score of 0.5 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutInfuSystem.

Are investors shorting InfuSystem?

InfuSystem saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 56,900 shares, an increase of 32.3% from the April 30th total of 43,000 shares. Based on an average daily volume of 93,500 shares, the short-interest ratio is presently 0.6 days. Currently, 0.3% of the shares of the company are sold short. View InfuSystem's Current Options Chain.

Who are some of InfuSystem's key competitors?

What other stocks do shareholders of InfuSystem own?

Who are InfuSystem's key executives?

InfuSystem's management team includes the following people:
  • Mr. Richard A. DiIorio, Pres, CEO & Director (Age 44)
  • Mr. Gregory Schulte, Exec. VP & CFO (Age 52)
  • Mr. Thomas Mark Ruiz, Sr. VP of Sales & Marketing
  • Mr. John Haggerty, Sr. VP of Biomedical Services & Logistics
  • Ms. Jean Pfeiffer, Sr. VP of Strategic Initiatives

What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

Who are InfuSystem's major shareholders?

InfuSystem's stock is owned by a variety of retail and institutional investors. Top institutional investors include Minerva Advisors LLC (9.17%), Teton Advisors Inc. (2.65%), Gabelli Funds LLC (1.04%), White Pine Capital LLC (0.95%), Millrace Asset Group Inc. (0.78%) and Hillsdale Investment Management Inc. (0.71%). Company insiders that own InfuSystem stock include Awm Investment Company, Inc, Barry G Steele, Christopher R Sansone, David C Dreyer, Gregg Owen Lehman, Jeannine Sheehan, Meridian Ohc Partners, Lp, Paul Andrew Gendron, Richard Dilorio, Ronald H Jr Peele, Scott Shuda, Terry L Armstrong and Thomas Mark Ruiz. View institutional ownership trends for InfuSystem.

Which institutional investors are selling InfuSystem stock?

INFU stock was sold by a variety of institutional investors in the last quarter, including Minerva Advisors LLC, Teton Advisors Inc., White Pine Capital LLC, Gabelli Funds LLC, Gamco Investors INC. ET AL, BlackRock Inc., and Alambic Investment Management L.P.. Company insiders that have sold InfuSystem company stock in the last year include Gregg Owen Lehman, Scott Shuda, and Thomas Mark Ruiz. View insider buying and selling activity for InfuSystem.

Which institutional investors are buying InfuSystem stock?

INFU stock was bought by a variety of institutional investors in the last quarter, including Millrace Asset Group Inc., Hillsdale Investment Management Inc., Geode Capital Management LLC, Jane Street Group LLC, State Street Corp, Wells Fargo & Company MN, HighTower Advisors LLC, and Acadian Asset Management LLC. Company insiders that have bought InfuSystem stock in the last two years include Awm Investment Company, Inc, Barry G Steele, Christopher R Sansone, Gregg Owen Lehman, Jeannine Sheehan, Meridian Ohc Partners, Lp, Paul Andrew Gendron, Richard Dilorio, Ronald H Jr Peele, Scott Shuda, and Terry L Armstrong. View insider buying and selling activity for InfuSystem.

How do I buy shares of InfuSystem?

Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is InfuSystem's stock price today?

One share of INFU stock can currently be purchased for approximately $11.77.

How big of a company is InfuSystem?

InfuSystem has a market capitalization of $236.22 million. InfuSystem employs 237 workers across the globe.

What is InfuSystem's official website?

The official website for InfuSystem is ir.infusystem.com.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.